Fibrocell Science, Inc. Proceeds from Convertible Debt
Fibrocell Science, Inc. reported Proceeds from Convertible Debt of $900.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2019-03-27
- Fibrocell Science, Inc. proceeds from convertible debt for the quarter ending 2017-12-31 was $7.62M.
- Fibrocell Science, Inc. proceeds from convertible debt for the quarter ending 2016-12-31 was $0.00.
- Fibrocell Science, Inc. proceeds from convertible debt for the quarter ending 2015-12-31 was $0.00.
- Fibrocell Science, Inc. proceeds from convertible debt for fiscal 2018 was $900.00K, a 88.19% decline from fiscal 2017.
- Fibrocell Science, Inc. proceeds from convertible debt for fiscal 2017 was $7.62M, a 57.49% decline from fiscal 2016.
- Fibrocell Science, Inc. proceeds from convertible debt for fiscal 2016 was $17.93M.
- Fibrocell Science, Inc. proceeds from convertible debt for fiscal 2015 was $0.00.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|
| 2018-12-31 | $900.00K 10-K · filed 2019-03-27 | ||
| 2017-12-31 | $7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $7.62M 10-K · filed 2019-03-27 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $17.93M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $17.93M 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 10-K · filed 2017-03-09 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 |